| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S1542-0124(12)70103-9 |
| P698 | PubMed publication ID | 18264653 |
| P50 | author | Jeanie Chui | Q43291533 |
| P2093 | author name string | Denis Wakefield | |
| Minas T Coroneo | |||
| Nick Di Girolamo | |||
| P2860 | cites work | Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C | Q83959973 |
| Heredity in one hundred patients admitted for excision of pterygia | Q93591240 | ||
| Long-term results after bare sclera pterygium resection with excimer smoothing and local application of mitomycin C | Q94500888 | ||
| The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors | Q22010018 | ||
| Pterygium as an early indicator of ultraviolet insolation: a hypothesis | Q24563206 | ||
| Topical ciclosporin in the treatment of ocular surface disorders | Q24670344 | ||
| Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review | Q24674561 | ||
| Epidermal growth factor receptor signaling is partially responsible for the increased matrix metalloproteinase-1 expression in ocular epithelial cells after UVB radiation | Q24675409 | ||
| The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2 | Q24684014 | ||
| The role of ultraviolet irradiation and heparin-binding epidermal growth factor-like growth factor in the pathogenesis of pterygium | Q24684329 | ||
| Ku, a DNA repair protein with multiple cellular functions? | Q28137885 | ||
| Evidence of oxidative stress in human corneal diseases | Q28201957 | ||
| The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it | Q28254798 | ||
| International Union of Pharmacology. LX. Retinoic acid receptors | Q28276127 | ||
| Serious complications of topical mitomycin-C after pterygium surgery | Q28317596 | ||
| Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia | Q28575259 | ||
| Angiogenesis: an organizing principle for drug discovery? | Q29614538 | ||
| TGF-beta and epithelial-to-mesenchymal transitions | Q29616456 | ||
| Evidence that fibroblasts derive from epithelium during tissue fibrosis | Q29616581 | ||
| Novel opportunities in the treatment and prevention of scarring | Q31140991 | ||
| Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia | Q31147742 | ||
| In vivo confocal imaging of corneal neovascularization | Q31973047 | ||
| Scar management: prevention and treatment strategies | Q33218798 | ||
| Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitro | Q33274890 | ||
| Safety profile of bevacizumab on cultured human corneal cells | Q33295166 | ||
| Calcitonin gene-related peptide stimulates proliferation of human endothelial cells | Q33554982 | ||
| Winglets of the eye: dominant transmission of early adult pterygium of the conjunctiva | Q33597854 | ||
| Pterygium and ultraviolet radiation: a positive correlation | Q33643262 | ||
| Growth factors: importance in wound healing and maintenance of transparency of the cornea | Q33805838 | ||
| Rapamycin inhibits corneal allograft rejection and neovascularization | Q72856048 | ||
| Inhibition of hepatic stellate cell proliferation and activation by the semisynthetic analogue of fumagillin TNP-470 in rats | Q73119481 | ||
| Roles of PPARs in health and disease. | Q33934899 | ||
| Age-related maculopathy and the impact of blue light hazard. | Q33993191 | ||
| Stimulation of epithelial cell growth by the neuropeptide substance P | Q34058565 | ||
| Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. | Q34158412 | ||
| Proliferative effects of heparin-binding epidermal growth factor-like growth factor on pterygium epithelial cells and fibroblasts | Q34285726 | ||
| mTOR inhibitors: an overview | Q34302240 | ||
| Intrastromal invasion by limbal epithelial cells is mediated by epithelial-mesenchymal transition activated by air exposure | Q34312592 | ||
| The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. | Q34317970 | ||
| Solar UV irradiation and dermal photoaging | Q34421848 | ||
| Acute response of human skin to solar radiation: regulation and function of the p53 protein | Q34421866 | ||
| Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic | Q34569109 | ||
| MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. | Q34572802 | ||
| Calcineurin inhibitors and rapamycin: cancer protection or promotion? | Q34578721 | ||
| Type I interferon receptors: biochemistry and biological functions. | Q34628239 | ||
| Current concepts and techniques in pterygium treatment | Q34637375 | ||
| Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest | Q34687606 | ||
| PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer | Q34768343 | ||
| Nuclear effects: unexpected intracellular actions of insulin-like growth factor binding protein-3. | Q34962746 | ||
| Ultraviolet-B irradiation and matrix metalloproteinases: from induction via signaling to initial events | Q35027219 | ||
| The treatment of pterygium | Q35103620 | ||
| Corneal nerves: structure, contents and function | Q35107870 | ||
| Microsatellite instability and loss of heterozygosity in human pterygia. | Q35300524 | ||
| Capillaries in the epithelium of pterygium | Q35302160 | ||
| Evaluation of loss of heterozygosity and microsatellite instability in human pterygium: clinical correlations. | Q35302853 | ||
| Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium | Q35313406 | ||
| The fate of limbal epithelial progenitor cells during explant culture on intact amniotic membrane | Q35391431 | ||
| Interferons: mechanisms of action and clinical applications | Q35587300 | ||
| No association of p53 codon 72 and p21 codon 31 polymorphisms in Taiwan Chinese patients with pterygium | Q35592238 | ||
| Characterisation of myofibroblasts in fibrovascular tissues of primary and recurrent pterygia | Q35592993 | ||
| Molecular mechanisms of neuroprotective action of immunosuppressants--facts and hypotheses. | Q35748218 | ||
| Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases | Q35749761 | ||
| Corneal epithelial stem cells at the limbus: looking at some old problems from a new angle | Q35755158 | ||
| Expression of insulin-like growth factor binding protein-3 in pterygium tissue | Q35769363 | ||
| Fibroblasts isolated from human pterygia exhibit transformed cell characteristics | Q41478615 | ||
| P53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors | Q41679881 | ||
| Interactions of the skin and nervous system | Q41714577 | ||
| Progenitor cells in healing after pterygium excision | Q42135449 | ||
| Expression of p27(KIP1) and cyclin D1, and cell proliferation in human pterygium | Q42288910 | ||
| Ocular surface toxicity associated with topical interferon alpha-2b | Q42410166 | ||
| Interferon alpha eye drops: treatment of atypical lymphoid hyperplasia with secondary alopecia | Q42410168 | ||
| Expression of vimentin by rabbit corneal epithelial cells during wound repair | Q42454452 | ||
| Involvement of bone marrow-derived stem and progenitor cells in the pathogenesis of pterygium | Q42458079 | ||
| Differential effects of epidermal growth factor and interleukin 6 on corneal epithelial cells and vascular endothelial cells | Q42475425 | ||
| In vivo corneal confocal microscopic findings of palisades of Vogt and its underlying limbal stroma | Q42476910 | ||
| The involvement of adult stem cells originated from bone marrow in the pathogenesis of pterygia | Q42485962 | ||
| Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbal epithelial basal cells | Q42491756 | ||
| Expression of p63 and p16 in primary and recurrent pterygia | Q42491771 | ||
| Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells | Q42504127 | ||
| Beta-catenin activation and epithelial-mesenchymal transition in the pathogenesis of pterygium | Q42510196 | ||
| MLH1 and MSH2 expression in pterygia | Q42511682 | ||
| Migration of 3T3 and lung fibroblasts in response to calcitonin gene-related peptide and bombesin | Q42815062 | ||
| In vitro antiangiogenic activity in ex vivo expanded human limbocorneal epithelial cells cultivated on human amniotic membrane. | Q42826911 | ||
| Postoperative subconjunctival 5-fluorouracil in the management of recurring pterygium | Q42840582 | ||
| Interferon treatment of childhood conjunctival lymphoma | Q43008360 | ||
| The NK1 receptor and its participation in the synergistic enhancement of corneal epithelial migration by substance P and insulin-like growth factor-1. | Q43167668 | ||
| Halting pterygium recurrence by postoperative 5-fluorouracil | Q43542516 | ||
| Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia | Q43757699 | ||
| Effects of cyclosporin A on human conjunctival fibroblasts | Q43762272 | ||
| Photoreactivation of ultraviolet radiation-induced basic fibroblast growth factor (bFGF) and the role of bFGF in corneal lesion formation in Monodelphis domestica | Q43825662 | ||
| Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors | Q44175822 | ||
| 5-Fluorouracil as chemoadjuvant for primary pterygium surgery: preliminary report | Q44527446 | ||
| Genetic polymorphism of hOGG1 and risk of pterygium in Chinese | Q44723563 | ||
| Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation. | Q44741825 | ||
| Antiinflammatory therapy for dry eye. | Q44763839 | ||
| TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model | Q45085906 | ||
| Age-related changes in superoxide dismutase, glutathione peroxidase, catalase and xanthine oxidoreductase/xanthine oxidase activities in the rabbit cornea | Q45121201 | ||
| Hyperexpression of low-density lipoprotein receptors and hydroxy-methylglutaryl-coenzyme A-reductase in human pinguecula and primary pterygium. | Q45124543 | ||
| Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca | Q45190856 | ||
| Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo | Q45238764 | ||
| Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon | Q45749666 | ||
| Blockade of TGF-beta by in vivo gene transfer of a soluble TGF-beta type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis | Q45873481 | ||
| CGRP increases the rate of corneal re-epithelialization in an in vitro whole mount preparation | Q46545329 | ||
| Adjuvant topical interferon-alpha-2b treatment in epithelial tumors of the ocular surface | Q46621269 | ||
| Increased oxidative DNA damage, 8-hydroxydeoxy- guanosine, in human pterygium. | Q46661621 | ||
| Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation | Q46811087 | ||
| Detection of point mutations at codon 12 of KI-ras in ophthalmic pterygia. | Q47251754 | ||
| Evaluation of TNF-alpha and IL-1beta polymorphisms in Taiwan Chinese patients with pterygium | Q47375806 | ||
| UVB-Elicited Induction of MMP-1 Expression in Human Ocular Surface Epithelial Cells Is Mediated through the ERK1/2 MAPK-Dependent Pathway | Q47423766 | ||
| Skin damage and mitochondrial dysfunction after acute ultraviolet B irradiation: relationship with nitric oxide production. | Q47683385 | ||
| Loss of heterozygosity and p53 expression in Pterygium | Q47956883 | ||
| H2O2 is an important mediator of UVB-induced EGF-receptor phosphorylation in cultured keratinocytes | Q47993793 | ||
| Expression of nuclear retinoic acid receptor and retinoid X receptor mRNA in the cornea and conjunctiva | Q48002577 | ||
| Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1 | Q35774769 | ||
| Immunolocalisation of E-cadherin and beta-catenin in human pterygium | Q35953948 | ||
| Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin) | Q35956190 | ||
| Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature | Q35975818 | ||
| 5-fluorouracil vs. beta-irradiation in the prevention of pterygium recurrence | Q35978239 | ||
| Age-related nuclear cataract-oxidation is the key. | Q36111043 | ||
| Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy | Q36165553 | ||
| The role of oxidative stress in glaucoma | Q36368431 | ||
| Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2 | Q36369190 | ||
| Cellular aspects of photocarcinogenesis | Q36390333 | ||
| Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis | Q36569348 | ||
| Regression of Experimental Iris Neovascularization with Systemic Alpha-interferon | Q36695100 | ||
| Nitric oxide in blood. The nitrosative-oxidative disequilibrium hypothesis on the pathogenesis of cardiovascular disease | Q36715892 | ||
| The clinical applications of fluorouracil in ophthalmic practice | Q36729597 | ||
| Diverse actions of retinoid receptors in cancer prevention and treatment. | Q36883185 | ||
| Role of mTOR in solid tumor systems: a therapeutical target against primary tumor growth, metastases, and angiogenesis | Q36916764 | ||
| A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis | Q36987028 | ||
| A role for NF-kappaB-dependent gene transactivation in sunburn. | Q37202396 | ||
| Pterygium excision with conjunctival autografting: an effective and safe technique | Q37303859 | ||
| Oculocutaneous manifestations in xeroderma pigmentosa | Q37305867 | ||
| Cell cycle kinetics in pterygium at three latitudes | Q37311320 | ||
| Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium | Q37580210 | ||
| Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation | Q38289991 | ||
| The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-kappa B (NF-kappa B)-inducing kinase to activate NF-kappa B. Identification of a novel receptor-tyrosine kinase signalosome | Q38305593 | ||
| Pterygial derived fibroblasts express functionally active histamine and epidermal growth factor receptors | Q39205948 | ||
| THE OCULAR EFFECTS OF VITAMIN A DEFICIENCY IN MAN IN THE TROPICS. | Q39403680 | ||
| Immunohistochemical study of p53, p21 and PCNA in pterygium | Q39540607 | ||
| Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand | Q39708256 | ||
| Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo | Q39801075 | ||
| Collagenase and other proteinases in the cornea of the retinol-deficient rat | Q39950956 | ||
| The role of substance P in the pathogenesis of pterygia. | Q40075689 | ||
| Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines | Q40148519 | ||
| All-trans retinoic acid antagonizes UV-induced VEGF production and angiogenesis via the inhibition of ERK activation in human skin keratinocytes | Q40261067 | ||
| Anti-proliferative effect of peroxisome proliferator-activated receptor gamma agonists on human malignant melanoma cells in vitro | Q40308015 | ||
| Interferon alpha 2a down-regulates VEGF expression through PI3 kinase and MAP kinase signaling pathways. | Q40468150 | ||
| Treatment of photodamage with topical tretinoin: an overview | Q41416427 | ||
| Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium | Q73138208 | ||
| H2O2 is required for UVB-induced EGF receptor and downstream signaling pathway activation | Q73370504 | ||
| Local chemotherapy with interferon-alpha for conjunctival mucosa-associated lymphoid tissue lymphoma: a preliminary report | Q73585661 | ||
| Calcitonin gene-related peptide induces IL-8 synthesis in human corneal epithelial cells | Q73644537 | ||
| Presence and possible significance of immunohistochemically demonstrable metallothionein expression in pterygium versus pinguecula and normal conjunctiva | Q73797082 | ||
| Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells | Q73800249 | ||
| Proliferative activity and p53 expression in primary and recurrent pterygia | Q73800672 | ||
| UVB-induced cyclobutane pyrimidine dimer frequency correlates with skin cancer mutational hotspots in p53 | Q73910280 | ||
| Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b | Q73947296 | ||
| Expression of stem cell factor in pterygium | Q74062940 | ||
| Cyclosporine reduces left ventricular mass with chronic aortic banding in mice, which could be due to apoptosis and fibrosis | Q74183611 | ||
| Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-beta | Q74210957 | ||
| Neurotrophic influences on corneal epithelial cells | Q74282200 | ||
| Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor | Q74489334 | ||
| Repeated subinflammatory ultraviolet B irradiation increases substance P and calcitonin gene-related peptide content and augments mustard oil-induced neurogenic inflammation in the skin of rats | Q74619742 | ||
| Overexpression of p53 tumor suppressor gene in pterygia | Q74651920 | ||
| Distribution of extracellular matrix proteins in pterygia: an immunohistochemical study | Q75356792 | ||
| Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs | Q77387249 | ||
| Expression of p53 protein in pterygium | Q77481771 | ||
| Molecular regulation of UVB-induced cutaneous angiogenesis | Q77519518 | ||
| Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b | Q77532280 | ||
| The effect of cyclosporin A on cultured rabbit subconjunctival fibroblast proliferation | Q77785093 | ||
| Surgically induced necrotizing scleritis after pterygium excision and conjunctival autograft | Q77829811 | ||
| Interaction of zinc and vitamin A on the ocular surface | Q78665720 | ||
| Angiogenesis in pterygium: morphometric and immunohistochemical study | Q78763445 | ||
| Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester retards vascular sprouting in angiogenesis | Q78818668 | ||
| Induction of matrix metalloproteinase-9 secretion from human keratinocytes in culture by ultraviolet B irradiation | Q79213663 | ||
| Ultraviolet fluorescence photography: patterns in established pterygia | Q79373861 | ||
| Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus | Q79424828 | ||
| [Exposure of Tenon's capsule fibroblasts of pterygium to cyclosporin 0.05%] | Q79712516 | ||
| Suppression of inflammation and structural damage in experimental arthritis through molecular targeted therapy with PPI-2458 | Q79844524 | ||
| Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1 | Q79845968 | ||
| Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits | Q80024594 | ||
| Tumor-volume increase at beginning of primary treatment with topical interferon alpha 2-beta in a case of conjunctiva-cornea intraepithelial neoplasia | Q80183172 | ||
| Subconjunctival bevacizumab for corneal neovascularization | Q80215584 | ||
| Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis | Q80381830 | ||
| Comparison of limbal-conjunctival autograft and intraoperative 0.02% mitomycin-C for treatment of primary pterygium | Q80762414 | ||
| Systemic remission of non-Hodgkin's lymphoma after intralesional interferon alpha-2b to bilateral conjunctival lymphomas | Q80871624 | ||
| Treatment of early pterygium recurrence with topical administration of interferon alpha-2b | Q80948315 | ||
| Temporary amniotic membrane patch for the treatment of primary pterygium: mechanisms of reducing the recurrence rate | Q81232447 | ||
| Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis | Q81588770 | ||
| UVB irradiation increases the release of SCF from human epidermal cells | Q81688983 | ||
| Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro | Q81735598 | ||
| Raman scattering properties of human pterygium tissue | Q81774514 | ||
| Investigation of nitric oxide in pterygium | Q82164007 | ||
| Inhibition of corneal neovascularization by rapamycin | Q83283294 | ||
| Endothelial progenitor cells in pterygium pathogenesis | Q83864171 | ||
| Modulation of cholesterol homeostasis by antiproliferative drugs in human pterygium fibroblasts. | Q50466826 | ||
| Mast cells in pterygium: number and phenotype. | Q50518695 | ||
| TNP-470 (a fungus-derived inhibitor of angiogenesis) reduces proliferation of cultured fibroblasts isolated from primary pterygia: a possible drug therapy for pterygia. | Q50522116 | ||
| Topical interferon alpha 2 beta therapy in the management of conjunctival papilloma. | Q50700331 | ||
| Fibroblasts isolated from human pterygia exhibit altered lipid metabolism characteristics. | Q50734739 | ||
| In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions. | Q50770519 | ||
| Characterization and distribution of bone marrow-derived cells in mouse cornea. | Q50779656 | ||
| Deficiency of glutathione S-transferases T1 and M1 as heritable factors of increased cutaneous UV sensitivity. | Q50978155 | ||
| Calcineurin inhibitors reduce nuclear localization of transcription factor NFAT in UV-irradiated keratinocytes and reduce DNA repair. | Q51141964 | ||
| Outcomes of autoconjunctival grafting for primary pterygia when performed by consultant compared with trainee ophthalmologists. | Q51998801 | ||
| Vascular endothelial growth factor causally contributes to the angiogenic response upon ultraviolet B irradiation in vivo. | Q52767251 | ||
| Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis. | Q52952533 | ||
| Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia. | Q53518458 | ||
| Enzyme-independent nitric oxide formation during UVA challenge of human skin: characterization, molecular sources, and mechanisms. | Q53596160 | ||
| UVB-mediated induction of cytokines and growth factors in pterygium epithelial cells involves cell surface receptors and intracellular signaling. | Q54600008 | ||
| Bone marrow-derived cells in normal human corneal stroma. | Q54623495 | ||
| Effect of p53 codon 72 polymorphism on p53 protein expression in pterygium. | Q54683733 | ||
| Topical alpha-interferon in recurrent conjunctival papilloma. | Q54773100 | ||
| Connective tissue growth factor in pterygium: simultaneous presence with vascular endothelial growth factor - possible contributing factor to conjunctival scarring. | Q54787565 | ||
| Overexpression of Insulin-like growth factor-binding protein-2 in pterygium body fibroblasts. | Q54792716 | ||
| Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1. | Q55067125 | ||
| Effects of rIFN Alpha, Beta, and Gamma on the Morphology, Proliferation, and Cell Surface Antigen Expression of Human Dermal Microvascular Endothelial Cells In Vitro | Q56657417 | ||
| Corneal Changes Associated With Chronic UV Irradiation | Q57245145 | ||
| Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis | Q57669695 | ||
| Ultraviolet radiation stimulates expression of Snail family transcription factors in keratinocytes | Q58394174 | ||
| Intraoperative and post operative treatment with 5-fluorouracil and mitomycin-c: long term effects in vivo on subconjunctival and scleral fibroblasts | Q67577740 | ||
| Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent | Q67682540 | ||
| Cultivation of human dermal microvascular endothelial cells in vitro: Immunocytochemical and ultrastructural characterization and effect of treatment with three synthetic retinoids | Q67901674 | ||
| Interleukin 6 facilitates corneal epithelial wound closure in vivo | Q68038290 | ||
| Interleukin 6 promotes epithelial migration by a fibronectin-dependent mechanism | Q68040795 | ||
| Modulation of rabbit keratocyte production of collagen, sulfated glycosaminoglycans and fibronectin by retinol and retinoic acid | Q68978097 | ||
| Topical retinoic acid in dysplastic and metaplastic keratinization of corneoconjunctival epithelium | Q69018424 | ||
| An investigation of aetiology and heredity of pterygium. Report of 11 cases in a family | Q69413338 | ||
| Topical retinoid treatment for various dry-eye disorders | Q69880484 | ||
| Topical retinoid therapy for squamous metaplasia of various ocular surface disorders. A multicenter, placebo-controlled double-masked study | Q70248173 | ||
| Immunologic basis for the pathogenesis of pterygium | Q70379137 | ||
| Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C | Q70556350 | ||
| Subconjunctival fibrosis after conjunctival autograft | Q70733281 | ||
| Substance P and nitric oxide mediate would healing of ultraviolet photodamaged rat skin: evidence for an effect of nitric oxide on keratinocyte proliferation | Q70958189 | ||
| Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-beta and tumor necrosis factor-alpha in the pterygium | Q71343752 | ||
| The tachykinin NK1 receptor mediates the migration-promoting effect of substance P on human skin fibroblasts in culture | Q71345757 | ||
| Stimulation of the chemotactic migration of human fibroblasts by substance P | Q71606688 | ||
| Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea | Q71615024 | ||
| Cyclosporin A is a substance P (tachykinin NK1) receptor antagonist | Q71735660 | ||
| Antiproliferative and synergistic effect of interferon alpha-2a, retinoids and their association in established human cancer cell lines | Q72105995 | ||
| Increased interleukin-1 activity in the injured vitamin A-deficient cornea | Q72360627 | ||
| Increased numbers of mast cells in pterygia | Q72437566 | ||
| Epithelial wound healing in the denervated cornea | Q72460884 | ||
| P433 | issue | 1 | |
| P921 | main subject | pathogenesis | Q372016 |
| pterygium | Q1862972 | ||
| P304 | page(s) | 24-43 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | The Ocular Surface | Q15764153 |
| P1476 | title | The pathogenesis of pterygium: current concepts and their therapeutic implications | |
| P478 | volume | 6 |
| Q53516902 | A comparative study of different concentrations of topical bevacizumab on the recurrence rate of excised primary pterygium: a short-term follow-up study. |
| Q50581470 | A novel graft option after pterygium excision: platelet-rich fibrin for conjunctivoplasty. |
| Q33832040 | Aberrant DNA methylation of matrix remodeling and cell adhesion related genes in pterygium |
| Q33914637 | Aberrant expression of genes and proteins in pterygium and their implications in the pathogenesis |
| Q35195192 | An update on the surgical management of pterygium and the role of loteprednol etabonate ointment |
| Q37097531 | Calcium-binding S100 protein expression in pterygium |
| Q37548603 | Chondrocyte-derived extracellular matrix suppresses pathogenesis of human pterygium epithelial cells by blocking the NF-κB signaling pathways |
| Q64986317 | Circular RNAs: Novel Promising Biomarkers in Ocular Diseases. |
| Q50580294 | Comparison of autologous fibrin glue versus nylon sutures for securing conjunctival autografting in pterygium surgery. |
| Q39098931 | Comparison of gene expression profiles in primary and immortalized human pterygium fibroblast cells |
| Q90150922 | Corneal Reinnervation and Sensitivity Recovery after Pterygium Excision |
| Q37051043 | Correlations Between Histopathologic Changes and Clinical Features in Pterygia |
| Q35645052 | Cyclooxygenase-2-expressing macrophages in human pterygium co-express vascular endothelial growth factor |
| Q90115068 | DNA methyltransferase inhibitor suppresses fibrogenetic changes in human conjunctival fibroblasts |
| Q53614805 | Effect of porcine chondrocyte-derived extracellular matrix on the pterygium in mouse model. |
| Q58762689 | Efficacy and Safety of Bevacizumab in the Treatment of Pterygium: An Updated Meta-Analysis of Randomized Controlled Trials |
| Q33598302 | Efficacy of curcumin in inducing apoptosis and inhibiting the expression of VEGF in human pterygium fibroblasts |
| Q30940749 | Expression analysis of human pterygium shows a predominance of conjunctival and limbal markers and genes associated with cell migration. |
| Q35820399 | Fixation and its role in the causation, laterality and location of pterygium: a study in amblyopes and non-amblyopes |
| Q92158443 | Identification and Interaction Analysis of Significant Genes and MicroRNAs in Pterygium |
| Q64102934 | Identification of pathogenic genes of pterygium based on the Gene Expression Omnibus database |
| Q50552869 | Identification of pterygium-related mRNA expression profiling by microarray analysis. |
| Q36690857 | Immunohistochemical detection of Hsp90 and Ki-67 in pterygium |
| Q90076641 | Impact of pterygium on the ocular surface and meibomian glands |
| Q36102681 | Influence of Light Emitting Diode-Derived Blue Light Overexposure on Mouse Ocular Surface |
| Q28469505 | Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13 |
| Q91833192 | Interferon Alpha-2b Eye Drops Prevent Recurrence of Pterygium After the Bare Sclera Technique: A Single-Center, Sequential, and Controlled Study |
| Q46343413 | Local pro-inflammatory cytokine and nitric oxide responses are elevated in patients with pterygium |
| Q28308320 | Localization of the low-affinity nerve growth factor receptor p75 in human limbal epithelial cells |
| Q42374084 | Low recurrence rate of anchored conjunctival rotation flap technique in pterygium surgery. |
| Q36574123 | Lymphatic microvessel density as a predictive marker for the recurrence time of pterygium: a three-year follow-up study. |
| Q92987907 | MiR-21 promotes pterygium cell proliferation through the PTEN/AKT pathway |
| Q34314409 | Molecular effects of doxycycline treatment on pterygium as revealed by massive transcriptome sequencing. |
| Q47954026 | Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis. |
| Q48348460 | Occupational Exposure to Solar Radiation at Different Latitudes and Pterygium: A Systematic Review of the Last 10 Years of Scientific Literature |
| Q58764503 | Ologen Implantation versus Conjunctival Autograft Transplantation for Treatment of Pterygium |
| Q34756125 | Ophthalmic pterygium: a stem cell disorder with premalignant features |
| Q42624145 | Ophthalmology in Persian medicine |
| Q89919437 | Optical Analysis and Reappraisal of the Peripheral Light Focusing Theory of Nasal Pterygia Formation |
| Q93013171 | Optical coherence tomography angiography for marginal corneal vascular remodelling after pterygium surgery with limbal-conjunctival autograft |
| Q34534444 | Oral doxycycline reduces pterygium lesions; results from a double blind, randomized, placebo controlled clinical trial |
| Q37482419 | Outdoor Air Pollution and Pterygium in Korea. |
| Q34475106 | Overexpression of urokinase-type plasminogen activator in pterygia and pterygium fibroblasts. |
| Q36048439 | Positive Association between Blood 25-Hydroxyvitamin D Levels and Pterygium after Control for Sunlight Exposure |
| Q36263397 | Prolidase Enzyme Activity in Conjunctiva and Pterygium Tissues. |
| Q34127741 | Proteomic analysis in pterygium; upregulated protein expression of ALDH3A1, PDIA3, and PRDX2. |
| Q47657903 | Pterygium: descriptive nomenclature of the past |
| Q47653081 | Pterygium: evolution of medical and surgical treatments. |
| Q53827430 | Pyroptosis in pterygium pathogenesis. |
| Q47111851 | Relationship between expression of cyclooxygenase 2 and neovascularization in human pterygia |
| Q37110100 | Relationship between the expression of cyclooxygenase-2 and survivin in primary pterygium. |
| Q58708834 | Solar Radiation Exposure and Outdoor Work: An Underestimated Occupational Risk |
| Q33760855 | Structure and biological roles of mucin-type O-glycans at the ocular surface |
| Q35924313 | Survivin and p53 expression in primary and recurrent pterygium in Chinese patients |
| Q55177567 | The Role of Limbal Epithelial Stem Cells in Regulating Corneal (Lymph)angiogenic Privilege and the Micromilieu of the Limbal Niche following UV Exposure. |
| Q90697233 | The in vitro anti-fibrotic effect of Pirfenidone on human pterygium fibroblasts is associated with down-regulation of autocrine TGF-β and MMP-1 |
| Q26753002 | The use of dry amniotic membrane in pterygium surgery |
| Q34347718 | Ultraviolet light and ocular diseases. |
| Q47094974 | Vitamin D and vitamin D receptor in patients with ophthalmic pterygium |
| Q84462988 | [Pterygium surgery. Complication following adjuvant radiotherapy] |
| Q84067006 | [Pterygium. Etiology, clinical aspects and novel adjuvant therapies] |
| Q34781453 | miRNA and mRNA expression profiling identifies members of the miR-200 family as potential regulators of epithelial-mesenchymal transition in pterygium |
| Q37195703 | p53 expression in pterygium in two climatic regions in Turkey |
Search more.